Dr. Asif Dhar is vice-chair and US Life Sciences and Health Care (LSHC) Industry leader for Deloitte LLP. He leads the overall strategic direction for the life sciences and healthcare practices, including audit, consulting, tax, and advisory services. He is a respected health leader who works with governments, life sciences, and healthcare clients on issues related to health equity, pandemic response, and recovery, and the Future of Health. Additionally, his expertise on cancer, real-world evidence, digital health, and innovation are sought by clients around the world. Among the client relationships he leads, Dr. Dhar is responsible for Deloitte’s work for the US Food and Drug Administration (FDA). Dr. Dhar is a cancer survivor, has a deep personal passion for tackling oncology problems, and has supported innovative cancer programs for more than 15 years. Dr. Dhar begins his service on the American Cancer Society Board of Directors in 2022.